MOA Illustrations of drugs in cancer immunotherapy.
Illustrations of the behavior of the protein LAG-3 (Lymphocyte-activation gene 3) and the mode of action of its soluble variant Eftilagimod Alpha (IMP321).
Content: 2 illustrations
Utilization: llustration Online, Print, PowerPoint
Specifications: 3000*2000 Pixel
Client: Immutep GmbH
The rights of use of the illustrations shown are with the respective clients.
Effect of the protein LAG-3 (lymphocyte-activation gene 3) in the immune system